How Genital Warts Are Treated at Home and in a Clinic

Genital warts can be treated with creams and solutions you apply yourself at home or with procedures performed in a clinic, and often a combination of both approaches works best. The main patient-applied options are imiquimod cream, podofilox solution or gel, and sinecatechins ointment, while clinic-based treatments include cryotherapy (freezing), trichloroacetic acid, electrodesiccation (burning), laser therapy, and surgical excision. Which route you end up on depends on the number, size, and location of your warts, as well as your preferences and what your provider recommends. The evidence on all of these treatments points to a shared frustration: clearing the visible warts is very achievable, but the virus that causes them lingers, so recurrences are common regardless of method.

Why You Need a Diagnosis Before You Treat Anything

Before reaching for any treatment, you need to confirm that what you’re seeing is actually a genital wart. Several other conditions look similar, including molluscum contagiosum, skin tags, seborrheic keratoses, and even certain skin cancers. A healthcare provider typically diagnoses genital warts through physical examination using bright light and magnification, and a biopsy is recommended when warts are fixed to underlying tissue, unusually discolored, or not responding to standard treatment.¹ Newer non-invasive imaging tools can identify features like thickened skin and enlarged blood vessels within the wart, and they can also help distinguish warts from look-alikes, though they’re not yet standard in most clinics.² Do not attempt to treat a bump yourself until a provider has confirmed what it is. Over-the-counter wart removers sold for hands and feet contain harsh acids that are not designed for genital skin and can cause serious chemical burns.

Home Treatments You Apply Yourself

Patient-applied therapies are prescribed by a clinician but used at home on your own schedule. They’re generally best suited for smaller, external warts and appeal to people who prefer privacy or want to avoid repeated clinic visits. Three medications have solid evidence behind them.

Imiquimod Cream

Imiquimod doesn’t destroy wart tissue directly. Instead, it stimulates your local immune response to recognize and attack the HPV-infected cells. You typically apply the cream three times a week at bedtime, wash it off in the morning, and continue for up to 16 weeks. Across trials involving people without HIV, about half of those using imiquimod achieved complete clearance, compared to roughly 6% on placebo. Around three-quarters saw their wart area shrink by at least half.³ The tradeoff for that immune boost is local skin reactions: redness, irritation, and sometimes erosion at the application site. These tend to be manageable but can be uncomfortable enough that some people take breaks from treatment.

One advantage of imiquimod is its relatively lower recurrence rate compared to methods that simply remove tissue. In the same pooled analysis, about 37% of patients treated with the 5% cream had complete clearance with no recurrence, versus 4% on placebo.³ Because the drug works through the immune system rather than just destroying visible tissue, it may address some of the surrounding subclinical infection that other approaches miss.

Podofilox (Podophyllotoxin)

Podofilox is an antimitotic agent, meaning it stops wart cells from dividing and eventually kills them. It comes as either a 0.5% solution or gel. The typical regimen is twice daily for three consecutive days, followed by four days off, repeated for up to four cycles. In a controlled trial of the gel formulation, about 37% of patients achieved complete clearance after four weeks, and by eight weeks only about 36% of baseline warts remained in the treated group compared to 88% in the placebo group.⁴ Local side effects are the main downside: inflammation, erosion, burning, and pain occur in roughly half of patients during the first week, though these reactions tend to be mild to moderate and fade over time.⁵

A persistent weakness of podofilox is recurrence. In one trial, complete wart disappearance was observed in over half of treatment courses, but only about one in five patients remained wart-free two weeks after finishing, and all patients available for long-term follow-up eventually saw warts come back.⁶ That high recurrence rate is a general limitation of treatments that work by destroying wart tissue without engaging the immune system. A large network meta-analysis found that podofilox 0.5% solution was the most effective patient-applied topical treatment for achieving complete clearance, outperforming both imiquimod cream and sinecatechins ointment in head-to-head comparisons.⁷

Sinecatechins (Green Tea Extract) Ointment

Sinecatechins ointment is derived from green tea polyphenols and works through multiple pathways, including antiviral and antiproliferative activity against HPV-infected cells.⁸ You apply it three times daily for up to 16 weeks. In a large randomized trial, complete clearance of all warts, including any new ones that appeared during treatment, occurred in about 57% of patients using the 15% formulation and 56% using 10%, compared to about 34% on placebo.⁹ Phase III trials have shown lower recurrence rates with sinecatechins compared to other patient-applied options, likely because of its mixed mechanism hitting HPV on several fronts simultaneously.¹⁰

The application schedule of three times daily for up to four months is more demanding than the other home options, and some people find it hard to stick with. Local reactions are common, though they’re generally tolerable. The ointment can stain underwear, which is a minor but practical annoyance.

Clinic-Based Procedures

When warts are large, numerous, in hard-to-reach locations like the anal canal or urethra, or resistant to topical treatment, in-office procedures become the better route. These can also make sense when you simply want faster visible results.

Cryotherapy

Cryotherapy uses liquid nitrogen to freeze and destroy wart tissue. It’s one of the most widely available clinic treatments. Each wart is frozen down to its base, sessions are typically repeated weekly, and most warts need multiple rounds. In one study of 50 women, the majority of warts responded after three sessions, and overall clearance was achieved in about 78% of patients, with a 4% recurrence rate at three months.¹¹ A head-to-head trial comparing treatments found 79% clearance with cryotherapy after up to six weekly sessions, with a three-month sustained clearance rate of 55%.¹² Cryotherapy hurts, especially in sensitive genital areas, but it doesn’t usually require local anesthesia and leaves little scarring.

Trichloroacetic Acid

Trichloroacetic acid (TCA) is a chemical cauterant applied directly to the wart surface by a clinician. It works by destroying the wart’s protein structure on contact. In a study of 51 women with isolated external warts, all lesions cleared with a median of four treatment sessions. During six months of follow-up no recurrences appeared, though in the second six months about 18% of patients developed new lesions.¹³ TCA causes a burning sensation during application that every patient in that study reported, and about 16% experienced ulceration, with scarring in a small number. A pilot trial comparing TCA to cantharidin found that cantharidin patients healed with less scarring, less pain during treatment, and needed fewer sessions to clear their warts.¹⁴ Cantharidin isn’t widely available everywhere, but it’s worth asking about if TCA’s side effects are a concern.

Electrodesiccation and Surgical Excision

Electrodesiccation uses an electric current to burn away wart tissue and is one of the most effective single-treatment options. In the comparative trial mentioned above, it achieved 94% initial clearance and a 71% three-month sustained clearance rate, outperforming both cryotherapy and podophyllin.¹² Surgical excision, where warts are cut out under local anesthesia, produces similar clearance rates and has the added advantage of providing tissue for biopsy if there’s any diagnostic uncertainty. According to a network meta-analysis, surgical excision was the most effective treatment for minimizing the risk of recurrence after initial clearance.⁷ Both procedures require local anesthesia and can leave scars, so they’re usually reserved for stubborn or extensive warts.

Laser Therapy

CO₂ laser therapy vaporizes wart tissue with high precision and can penetrate deeper than cryotherapy, making it useful for thick, extensive, or hard-to-reach lesions such as warts inside the anal canal, urethra, or vagina.¹⁵ The same network meta-analysis ranked CO₂ laser therapy as the single most effective treatment for achieving complete clearance at the end of treatment.⁷ The downsides are cost, the need for local or sometimes general anesthesia, and limited availability in general practice settings. Most clinicians reserve lasers for refractory cases where other methods have failed.

Why Warts Come Back and What You Can Do About It

Recurrence is the defining frustration of genital wart treatment. Every method, whether at home or in a clinic, removes or destroys the visible wart, but the underlying HPV infection persists in surrounding skin cells. Surgical therapies including cryotherapy, electrodesiccation, laser, and excision are generally similar in their clearance rates but all share high rates of recurrence.¹⁶ The virus itself cannot be eliminated with any current therapy. Your immune system may eventually suppress HPV on its own, and many people do clear the infection over months to years, but during that window warts can reappear.

This reality changes how you should think about treatment “success.” A treatment that initially clears your warts is doing its job; a recurrence doesn’t mean it failed. Many people go through two or three rounds of treatment, sometimes combining a home topical with an in-clinic procedure, before warts stay away for good. If your first approach doesn’t work or warts return quickly, switching to a different mechanism of action is a reasonable strategy. For instance, if podofilox clears your warts but they return within weeks, adding imiquimod or sinecatechins, which engage the immune system, could help address the underlying infection rather than just the visible growth.

Treatment During Pregnancy and for People With HIV

Pregnancy changes the treatment calculus significantly because some medications carry risks for the developing fetus. Podofilox and 5-fluorouracil are generally avoided during pregnancy. Cryotherapy, laser therapy, and imiquimod have all been used during pregnancy without severe adverse effects, though one review cautiously recommends reserving laser therapy for the third trimester to reduce the risk of recurrence before delivery.¹⁷ Warts can grow rapidly during pregnancy due to hormonal and immune changes, and large warts in the birth canal can occasionally obstruct delivery. Treatment decisions during pregnancy should involve both a dermatologist or sexual health specialist and the obstetrician.

People living with HIV face a particularly difficult course. They carry a higher burden of HPV infection and are more susceptible to treatment failures and recurrences.¹⁸ Imiquimod has been studied in HIV-positive men, and about a third achieved complete clearance by 20 weeks, with results not significantly influenced by CD4 count or viral load. Among those who cleared, about 29% experienced recurrence, with warts returning on average about 14 weeks later.¹⁹ These numbers are lower than in the general population, but they show that treatment is still worthwhile. People with HIV often benefit from more aggressive clinic-based approaches, closer monitoring, and combination strategies.

HPV Vaccination After Treatment

Getting vaccinated against HPV after you’ve already been treated for genital warts is a surprisingly common question, and the answer is encouraging. Vaccination doesn’t treat existing warts, but it may reduce recurrence and protect against HPV strains you haven’t yet encountered. In one study comparing vaccinated and unvaccinated women after wart treatment, recurrence rates were numerically lower in the vaccinated group (about 12% versus 22%), and the average time until any recurrence was substantially longer for vaccinated women: about 44 weeks compared to 16 weeks in the unvaccinated group.²⁰

A large systematic review and meta-analysis focused on cervical precancer found that women vaccinated around the time of surgical treatment had a substantially lower risk of recurrence of high-grade lesions. However, the evidence specifically for genital warts and other conditions was limited by a small number of studies and participants.²¹ Still, many sexual health guidelines now recommend vaccination for eligible individuals even after a genital wart diagnosis, since the vaccine covers multiple HPV types and you’re unlikely to have been exposed to all of them.

The Emotional Weight of a Diagnosis

The psychological burden of genital warts is real and consistently underestimated in clinical settings. Studies show that people with genital warts report significantly higher rates of depression and anxiety compared to the general population, along with lower scores on measures of mental health, general health, and social functioning.²² A large cross-sectional study in South Korea found that the vast majority of men with genital warts and nearly nine in ten women with HPV-related conditions reported moderate to high psychological impact, with particular hits to emotional health and sexual activity.²³

Qualitative research paints a more textured picture. People describe the uncertain timeline of treatment and recurrence as one of the hardest aspects to deal with, often more distressing than the physical symptoms themselves. The disease affects sex lives and romantic relationships, and the stigma around sexually transmitted infections compounds the emotional toll.²⁴ If you’re struggling with the emotional side, that’s not unusual or a sign of weakness. Talking with a sexual health counselor, joining a support community, or simply being honest with a trusted friend can relieve some of the isolation that many people describe as worse than the warts themselves.

Choosing a First-Line Approach

With so many options, the decision can feel overwhelming. A few practical considerations narrow the field quickly. If you have a small number of external warts and prefer to manage treatment privately at home, podofilox or sinecatechins ointment are reasonable starting points: podofilox for faster clearance over a few weeks, sinecatechins for potentially lower recurrence over a longer treatment window. If you want your immune system involved in the fight, imiquimod is the go-to home option. For warts that are large, clustered, internal, or resistant to topicals, clinic procedures are the stronger choice. CO₂ laser therapy and surgical excision offer the highest clearance rates, while cryotherapy offers a solid balance between effectiveness and accessibility.

Whatever you start with, you should expect that this might not be a one-treatment story. Having a follow-up plan with your provider, including when to switch approaches if things aren’t improving after a set number of weeks, turns what can feel like an endless cycle into a structured process. The evidence is reassuring on one point: for most immunocompetent people, genital warts eventually resolve, and finding the right treatment or combination of treatments speeds that timeline considerably.

1
Clinical Infectious Diseases. External Genital Warts: Diagnosis, Treatment, and Prevention
2
PubMed Central. Non-Invasive Imaging for the Diagnosis of Genital Warts and Their Imitators
3
PubMed Central. Imiquimod for the treatment of genital warts: a quantitative systematic review
4
Archives of Dermatology. Safety and Efficacy of 0.5% Podofilox Gel in the Treatment of Anogenital Warts
5
PubMed. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts
6
The American Journal of Medicine. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts
7
BMJ Open. Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis
8
PubMed Central. Sinecatechins: Effects on HPV-Induced Enzymes Involved in Inflammatory Mediator Generation
9
PubMed. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial
10
PubMed. Sinecatechins 10% ointment: a green tea extract for the treatment of external genital warts
11
PubMed Central. Cryotherapy of Genital Warts
12
Sexually Transmitted Infections. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation
13
PubMed. Therapeutic value of trichloroacetic acid in the treatment of isolated genital warts on the external female genitalia
14
PubMed Central. Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial
15
PubMed Central. CO 2 Laser therapy versus cryotherapy in treatment of genital warts; a Randomized Controlled Trial (RCT)
16
PubMed. Critical appraisal of commonly used treatment for genital warts
17
PubMed Central. Management of Condyloma Acuminata in Pregnancy: A Review
18
Sexually Transmitted Infections. Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials
19
PubMed. Effect of imiquimod in anogenital warts from HIV-positive men
20
PubMed. The relationship between the recurrence rate of genital warts and administration of quadrivalent human papilloma virus vaccine in women
21
BMJ. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
22
PubMed Central. Evaluation of Psychopathology and Quality of Life in Patients with Anogenital Wart Compared to Control Group
23
PubMed Central. Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea
24
PubMed Central. The quality of life of patients with genital warts: a qualitative study